Intermittent PTH injection is a promising treatment for osteoporosis, which afflicts millions. Recent evidence suggests that this treatment strategy may fail in patients with hyperlipidemia. Osteoporosis has been associated with hyperlipidemia in an age-independent manner. In the hyperlipidemic condition, bioactive derivatives of low-density lipoproteins (LDL) are generated in the subendothelial space of tissues, triggering inflammatory processes such as atherosclerosis. We have found that these inflammatory lipoproteins are also present in bone, and they inhibit osteoblastic differentiation. In additional studies, we found that hyperlipidemic mice have reduced bone density compared to normolipemic mice. Our preliminary studies, both in vitro and in vivo, now show that inflammatory lipoproteins also inhibit PTH-induced primary response genes, including Nurrl, a transcriptional regulator of osteoblastic genes, strongly suggesting that hyperlipidemia may also interfere with anabolic effects of PTH. Since hyperlipidemia remains widespread despite treatment, understanding its effects on bone metabolism may be crucial for devising effective PTH treatments. ? In this exploratory proposal, we hypothesize that hyperlipidemia, through inflammatory lipoproteins, reduces PTH anabolic effects. Based on our preliminary studies, in Specific Aim 1. we will test whether the mechanism of lipid inhibition of Nurrl expression is at the level of PKA activation or downstream at the level of promoter stimulation by transcription factor cAMP-response element binding protein (CREB), and its coactivator, CREB binding protein (CBP/p300).
In Specific Aim 2. we will test whether hyperlipidemia reduces PTH-induced bone anabolism in vivo using intermittent PTH injection in normolipemic control (C57BL/6) and genetically hyperlipidemic Idlr(-/-) and apoE(-/-) mice. These proposed studies are expected to reveal how inflammatory lipids affect PTH-induced anabolism and the site of inhibitory activity within the intracellular signaling pathway. If successful, the findings will set the stage for a future R01 application to identify therapeutic strategies that rescue PTH efficacy in the face of hyperlipidemia. Such knowledge may significantly impact pharmacological interventions for osteoporosis. ? ? Lay Summary. High cholesterol is common in patients with the low bone density disease, osteoporosis. Recent studies suggest that the promising new therapy for osteoporosis, intermittent parathyroid hormone injection, may be significantly less effective in those with high cholesterol. The proposed studies will determine how high cholesterol reduces efficacy of parathyroid hormone so that corrective strategies can be developed. ? ? ?
| Geng, Yifan; Hsu, Jeffrey J; Lu, Jinxiu et al. (2011) Role of cellular cholesterol metabolism in vascular cell calcification. J Biol Chem 286:33701-6 |
| Ting, Tabitha C; Miyazaki-Anzai, Shinobu; Masuda, Masashi et al. (2011) Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J Biol Chem 286:23938-49 |
| Sage, Andrew P; Lu, Jinxiu; Atti, Elisa et al. (2011) Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids. J Bone Miner Res 26:1197-206 |
| Demer, Linda; Tintut, Yin (2010) The bone-vascular axis in chronic kidney disease. Curr Opin Nephrol Hypertens 19:349-53 |
| Demer, Linda L; Tintut, Yin (2009) Mechanisms linking osteoporosis with cardiovascular calcification. Curr Osteoporos Rep 7:42-6 |
| Hsu, Jeffrey J; Lu, Jinxiu; Huang, Michael S et al. (2009) T0901317, an LXR agonist, augments PKA-induced vascular cell calcification. FEBS Lett 583:1344-8 |
| Sage, Andrew; Tintut, Yin; Garfinkel, Alan et al. (2009) Systems biology of vascular calcification. Trends Cardiovasc Med 19:118-23 |
| Demer, Linda L; Sage, Andrew P; Tintut, Yin (2008) Nanoscale architecture in atherosclerotic calcification. Arterioscler Thromb Vasc Biol 28:1882-4 |
| Demer, Linda L; Tintut, Yin (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117:2938-48 |
| Huang, Michael S; Sage, Andrew P; Lu, Jinxiu et al. (2008) Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification. Biochem Biophys Res Commun 374:553-8 |
Showing the most recent 10 out of 13 publications
